Pfizer has increased its expectation for Covid vaccine sales to $36 billion in 2021.
Pfizer boosted its income expectation from coronavirus vaccine sales to USD36 billion (PHP1.8 trillion) for 2021, according to a financial statement released Tuesday.
Previous predictions for 2021 from the US pharmaceutical industry were USD33.5 billion in July, and USD26 billion and USD15 billion in May and February, respectively.
According to the business, the increased revision in the sales projection is due to greater vaccine doses expected to be distributed in 2021, totalling an anticipated 2.3 billion globally.
The US Food and Drug Administration authorized Pfizer-Covid-19 BioNTech’s vaccine for children aged 5 to 11 on Friday, paving the way for millions more jabs in children’s arms.
In the third quarter, Pfizer’s sales increased by 134 percent to USD24.1 billion, up from USD10.27 billion the previous year.
On the New York Stock Exchange, its stock rose 3.3 percent to USD45.09.
Save/Share this story with QR CODE
Disclaimer: This article is for informational purposes only and does not constitute endorsement of any specific technologies or methodologies and financial advice or endorsement of any specific products or services.
📩 Need to get in touch? Feel free to Email Us for comments, suggestions, reviews, or anything else.
We appreciate your reading. 😊Simple Ways To Say Thanks & Support Us:
1.) ❤️GIVE A TIP. Send a small donation thru Paypal😊❤️
Your DONATION will be used to fund and maintain NEXTGENDAY.com
Subscribers in the Philippines can make donations to mobile number 0917 906 3081, thru GCash.
3.) 🛒 BUY or SIGN UP to our AFFILIATE PARTNERS.
4.) 👍 Give this news article a THUMBS UP, and Leave a Comment (at Least Five Words).
World Class Nutritional Supplements - Buy Highest Quality Products, Purest Most Healthy Ingredients, Direct to your Door! Up to 90% OFF.
Join LiveGood Today - A company created to satisfy the world's most demanding leaders and entrepreneurs, with the best compensation plan today.